Answers are grounded in this paper and cite their sources.
Patients with localized pancreatic adenocarcinoma who do not respond to neoadjuvant therapy present a challenge. We sought to define the characteristics and outcomes of those patients to guide clinical practice.
No takes yet. Share an insight, caveat, or question.
Hagerty et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: